Search results
Results from the WOW.Com Content Network
It is headquartered in Bonn, Germany. The core tasks of the BfArM as a regulatory authority include the approval and registration of medical devices and products, including drugs in the special therapeutic areas of herbalism and paraherbals, as well as the identification, assessment and defence against drug risks (pharmacovigilance).
The following drugs are controlled by the German Narcotic Drugs Act (German: Betäubungsmittelgesetz or BtMG). Trade and possession of these substances without licence or prescription is considered illegal; prescription is illegal for drugs on Anlage I and II and drugs on Anlage III require a special prescription form.
In Germany, several laws govern drugs (both recreational and pharmaceutical). Narcotic Drugs Act (Betäubungsmittelgesetz, BtMG), regulates narcotics and contains explicit lists of those covered: Anlage I (authorized scientific use only), Anlage II (authorized trade only, not prescriptible) and Anlage III (special prescription form required).
Germany Kidney damage [3] Buformin: 1978 Germany Metabolic toxicity. [3] Bunamiodyl: 1963 Canada, UK, US Nephropathy. [11] Butamben (Efocaine)(Butoforme) 1964 US Dermatologic toxicity; psychiatric reactions. [3] Canrenone: 1986 Germany Animal Carcinogenicity. [3] Cerivastatin (Baycol, Lipobay) 2001 US Risk of rhabdomyolysis [2] Chlormadinone ...
FRANKFURT (Reuters) -German regulator BfArM is considering banning Ozempic exports as Europe's health systems grapple with shortage of the diabetes drug, which is in high demand for its weight ...
Supplies of Novo Nordisk's popular weight-loss drug Wegovy are limited in Germany less than a month after its launch in Europe's largest drug market, major drug distributors and doctors told Reuters.
Council Decision 2003/847/JHA of 27 November 2003 concerning control measures and criminal sanctions in respect of the new synthetic drugs 2C-I, 2C-T-2, 2C-T-7 and TMA-2 Decisions based on Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances :
The drug, shown to help patients reduce body weight by around 15% when used along with exercise and lifestyle changes, is already available in the United States, but in Europe is so far on sale ...